Skip to search formSkip to main contentSkip to account menu

Therapy-Related Acute Myeloid Leukemia

Known as: Treatment Related AML, t-AML, Treatment-Related Acute Myelocytic Leukemia 
An acute myeloid leukemia arising as a result of the mutagenic effect of chemotherapy agents and/or ionizing radiation. (WHO, 2001)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Secondary acute myeloid leukemia (s-AML) refers to patients with either therapy-related AML (t-AML), that is, AML after treatment… 
2017
2017
Capecitabine is an oral agent that is used either as single agent or in combination therapy. Therapy related acute myeloblastic… 
2013
2013
Therapy-related acute myelogenous leukemia (t-AML) remains difficult to distinguish from de novo leukemia, and the overall… 
Review
2013
Review
2013
To the Editor: Breast cancer survival rates have improved due to better diagnosis performed on the basis of tumor characteristics… 
2011
2011
We conclude that MLL breakage and religation in the topoisomerase-sensitive bcr, leading to MLL rearrangements (deletions… 
2009
2009
Continuous immunosuppressive treatment after solid organ transplantation is associated with an increased incidence of therapy… 
Review
2004
Review
2004
Introduction: Studies of A-bomb survivors and radiotherapy/chemotherapy patients have shown that whole body acute exposure to… 
1999
1999
Twenty-one children who developed therapy-related acute myeloid leukemia after treatment for acute lymphoblastic leukemia… 
1998
1998
Therapy-related acute myeloid leukemias with balanced translocations affecting the 11q23 chromosome region are one of the most…